Although Michael acceptors are traditionally shunned in modern drug discovery, trapping of thiols by covalent coupling represents an important mechanism of bioactivity, and many biologically relevant and druggable pathways are targeted by thiol-reactive compounds. Research on Michael acceptors, long confined to the realm of toxicology, was rekindled by the development of the antioxidant inflammation modulator (AIM) homo-triterpenoid bardoxolone methyl (RTA402, 1). This orally bioavailable biological
An NMR spectroscopic method to identify and classify thiol-trapping agents: revival of Michael acceptors for drug discovery?
Cristina Avonto,O. Taglialatela‐Scafati,F. Pollastro,Alberto Minassi,V. Di Marzo,L. De Petrocellis,G. Appendino
Published 2011 in Angewandte Chemie
ABSTRACT
PUBLICATION RECORD
- Publication year
2011
- Venue
Angewandte Chemie
- Publication date
2011-01-10
- Fields of study
Medicine, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-38 of 38 references · Page 1 of 1